These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9025964)

  • 21. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
    Boehm MK; Woof JM; Kerr MA; Perkins SJ
    J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization.
    Huang L; Biolsi S; Bales KR; Kuchibhotla U
    Anal Biochem; 2006 Feb; 349(2):197-207. PubMed ID: 16360109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of IgG1 immunoglobulins and peptide-Fc fusion proteins by limited proteolysis in conjunction with LC-MS.
    Kleemann GR; Beierle J; Nichols AC; Dillon TM; Pipes GD; Bondarenko PV
    Anal Chem; 2008 Mar; 80(6):2001-9. PubMed ID: 18293943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural effect of a recombinant monoclonal antibody on hinge region peptide bond hydrolysis.
    Xiang T; Lundell E; Sun Z; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):254-62. PubMed ID: 17901002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cetuximab Fab and Fc N-glycan fast characterization using IdeS digestion and liquid chromatography coupled to electrospray ionization mass spectrometry.
    Janin-Bussat MC; Tonini L; Huillet C; Colas O; Klinguer-Hamour C; Corvaïa N; Beck A
    Methods Mol Biol; 2013; 988():93-113. PubMed ID: 23475716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the proteolytic fragments of bovine colostral IgG1.
    Wie SI; Dorrington KJ; Froese A
    J Immunol; 1978 Jul; 121(1):98-104. PubMed ID: 78949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice.
    Parham P
    J Immunol; 1983 Dec; 131(6):2895-902. PubMed ID: 6358356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering a unique glycosylation site for site-specific conjugation of haptens to antibody fragments.
    Leung S; Losman MJ; Govindan SV; Griffiths GL; Goldenberg DM; Hansen HJ
    J Immunol; 1995 Jun; 154(11):5919-26. PubMed ID: 7751635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody.
    Liu H; Bulseco GG; Sun J
    Immunol Lett; 2006 Aug; 106(2):144-53. PubMed ID: 16831470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry.
    Zhang Z; Shah B
    Anal Chem; 2007 Aug; 79(15):5723-9. PubMed ID: 17591752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of immunoglobulin G glycosylation in monoclonal and polyclonal species by electrospray and matrix-assisted laser desorption/ionization mass spectrometry.
    Saba JA; Kunkel JP; Jan DC; Ens WE; Standing KG; Butler M; Jamieson JC; Perreault H
    Anal Biochem; 2002 Jun; 305(1):16-31. PubMed ID: 12018942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region-selective labeling of antibodies as determined by electrospray ionization-mass spectrometry (ESI-MS).
    Adamczyk M; Gebler J; Shreder K; Wu J
    Bioconjug Chem; 2000; 11(4):557-63. PubMed ID: 10898578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agments.
    Govindan SV; Goldenberg DM; Griffiths GL; Leung SO; Losman MJ; Hansen HJ
    Cancer Res; 1995 Dec; 55(23 Suppl):5721s-5725s. PubMed ID: 7493334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural characterization of intact antibodies by high-resolution LTQ Orbitrap mass spectrometry.
    Zhang J; Liu H; Katta V
    J Mass Spectrom; 2010 Jan; 45(1):112-20. PubMed ID: 19943324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions.
    Valliere-Douglass J; Wallace A; Balland A
    J Chromatogr A; 2008 Dec; 1214(1-2):81-9. PubMed ID: 19012891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid.
    Ryan MH; Petrone D; Nemeth JF; Barnathan E; Björck L; Jordan RE
    Mol Immunol; 2008 Apr; 45(7):1837-46. PubMed ID: 18157932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production and molecular characterization of clinical phase i anti-melanoma mouse IgG3 monoclonal antibody R24.
    Kemminer SE; Conradt HS; Nimtz M; Sagi D; Peter-Katalinić J; Diekmann O; Drmić I; Müthing J
    Biotechnol Prog; 2001; 17(5):809-21. PubMed ID: 11587568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of two species of Fc fragments obtained from rat IgG2a by prolonged papain digestion.
    Arend WP; Hermodson MA; Teller DC
    J Immunol; 1977 Feb; 118(2):388-94. PubMed ID: 402415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the interface structure of enzyme-inhibitor complex by using hydrogen-deuterium exchange and electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
    Akashi S; Takio K
    Protein Sci; 2000 Dec; 9(12):2497-505. PubMed ID: 11206071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of antibody Fab and F(ab')2 fragments using Gradiflow technology.
    Cheung GL; Thomas TM; Rylatt DB
    Protein Expr Purif; 2003 Nov; 32(1):135-40. PubMed ID: 14680950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.